Sexually transmitted co-infections increase HIV risk: study

by Chantall Van Raay

(Medical Xpress) -- Bacterial and viral sexually transmitted infections can exacerbate HIV replication in co- infected individuals, a team of Canadian researchers led by Charu Kaushic, associate professor of pathology and molecular medicine, has found.

"While sexually transmitted infections are associated with increased HIV-1 susceptibility and viral shedding in the genital tract, the mechanisms underlying this association are poorly understood," said Kaushic about the study that appears online this month in the . "Our research has found that normal response to these infections by the epithelial cells (the cells that line the genital tract) can lead to increased in the ."

Through this study, Victor Ferreira, a graduate student in Kaushic's lab revealed how bacterial (gonorrhoea) and viral () sexually transmitted infections can increase HIV replication in co-infected individuals, opening new doors of understanding.

"Clinical studies have clearly shown that co-infection with herpes and gonorrhoea makes HIV infection worse and large trials have been conducted to study if controlling these infections can make less invasive and less transmissible," says Kaushic, a member of McMaster's Institute for Infectious Disease Research.

"The benefit of treating co-infections has not been as impressive as was expected, and this study increases our understanding of why that might be. We discovered that inflammation plays a key role in HIV replication. It's not necessary that if you control those infections, the inflammation is gone. So it might be useful, that in addition to treating these co- infections with antibiotics or antivirals, to control the inflammation and this might be more effective in stopping HIV replication rather than controlling just the infection."

add to favorites email to friend print save as pdf

Related Stories

Herpes drug inhibits HIV replication, but with a price

Nov 06, 2008

The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. This beneficial effect does pose a risk though, as HIV-in ...

Recommended for you

Preventing one case of HIV saves over $225K, study shows

Feb 27, 2015

How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new study led by a researcher at Weill Cornell Medical College and published online Feb. 24 in Medical Care, answer ...

Research captures transient details of HIV genome packaging

Feb 27, 2015

Once HIV-1 has hijacked a host cell to make copies of its own RNA genome and viral proteins, it must assemble these components into new virus particles. The orchestration of this intricate assembly process falls to a viral ...

Could an HIV drug beat strep throat, flesh-eating bacteria?

Feb 25, 2015

With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.